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Background: Fatigue is a distressing, complex, multidimensional sensation common in 
  individuals with chronic obstructive pulmonary disease (COPD). While fatigue negatively 
impacts functional performance and quality of life, there has been little study of the fatigue 
that affects participants in pulmonary rehabilitation programs. The purpose of this study was 
to examine the emotional, behavioral, cognitive, and physical dimensions of fatigue and their 
relationships to dyspnea, mental health, sleep, and physiologic factors.
Patients and methods: A convenience sample of 42 pulmonary rehabilitation participants 
with COPD completed self-report questionnaires which measured dimensions of fatigue using 
the Multidimensional Fatigue Inventory, anxiety and depression using the Hospital Anxiety 
and Depression Scale, and sleep quality using the Pittsburgh Sleep Quality Index. Data on other 
clinical variables were abstracted from pulmonary rehabilitation program health records.
Results: Almost all (95.3%) participants experienced high levels of physical fatigue. High levels 
of fatigue were also reported for the dimensions of reduced activity (88.1%), reduced motiva-
tion (83.3%), mental fatigue (69.9%), and general fatigue (54.5%). Close to half (42.9%) of 
participants reported symptoms of anxiety, while almost one quarter (21.4%) reported depressive 
symptoms. Age was related to the fatigue dimensions of reduced activity (ρ = 0.43, P , 0.01) and 
reduced motivation (ρ = 0.31, P , 0.05). Anxiety was related to reduced motivation (ρ = −0.47, 
P , 0.01). Fatigue was not associated with symptoms of depression, sleep quality, gender, 
supplemental oxygen use, smoking status, or Medical Research Council dyspnea scores.
Conclusions: Fatigue (particularly the physical and reduced motivation dimensions of fatigue) 
was experienced by almost all participants with COPD attending this pulmonary rehabilitation 
program. Fatigue affected greater proportions of participants than either anxiety or depression. 
The high prevalence of fatigue may impact on enrolment, participation, and attrition in pul-
monary rehabilitation programs. Further investigation of the nature, correlates, and impact of 
fatigue in this population is required.
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Introduction
Chronic obstructive pulmonary disease (COPD) is a debilitating lung condition that 
manifests in shortness of breath, activity limitation, increased sputum production, and 
cough.1 Currently the fifth leading cause of death and disease burden globally,1 COPD 
is characterized by significant physical and psychosocial challenges. In contrast with a 
prevalence rate of 18.3%–25% in the general population,2,3 fatigue is “almost always” 
experienced by 43%–58% of persons with COPD.4–6 Fatigue is one of the most distress-
ing symptoms of this illness,7,8 and significantly impairs both functional performance 
and quality of life.9,10 The aim of this study was to examine fatigue in individuals with International Journal of Chronic Obstructive Pulmonary Disease 2010:5 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
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COPD enrolled in a pulmonary rehabilitation program from 
a multidimensional perspective and to assess the relationship 
of fatigue to anxiety, depression, sleep quality, dyspnea, and 
physiologic factors.
Individuals living with COPD in the community have 
a moderate to high prevalence of symptoms.6 The experi-
ence of unpleasant symptoms, such as fatigue, contributes 
to impaired quality of life.11 Fatigue imposes limitations 
on motivation, concentration, and the ability to engage in 
everyday activities such as work, household chores, and 
social pastimes,12 engendering frustration, depression, grief, 
and a sense of loss of control.13
Measurement of fatigue has been plagued by a lack of 
consensus on its definition,14,15 and a lack of agreement on 
its dimensions.16 For the purposes of this study, fatigue 
was defined as “a subjective, unpleasant symptom which 
incorporates total body feelings ranging from tiredness to 
exhaustion, creating an unrelenting overall condition which 
interferes with individuals’ ability to function to their normal 
capacity”.13 The Multidimensional Fatigue Inventory (MFI) 
was used in this study,17 and has been found to be valid 
and reliable in measuring fatigue in the chronically unwell 
population.17
Moderate to strong positive relationships have been 
reported between fatigue and mood states such as anxiety, 
irritability and depression,5,18 and sleep quality.14 In primary 
care populations, patients with fatigue receive a lifetime 
diagnosis of depression or anxiety more frequently than 
those without fatigue,19 and there appears to be a longitudinal 
relationship between the severity of fatigue and impaired 
functioning and psychologic symptoms.20 Poor quality of 
sleep is a common symptom among older adults, and has 
been attributed in large part to the presence of chronic illness 
in this population.21
While fatigue has been found to be related to dyspnea,22 
it does not appear to be directly related to measures of pul-
monary function.10 Pulmonary rehabilitation programs are 
designed to optimize physical and social performance and 
autonomy1 in persons with COPD. The efficacy of pulmonary 
rehabilitation programs in improving functional capacity and 
disease-specific health perception is well documented.23
Fatigue has not been a major focus of study to date in 
persons with COPD attending pulmonary rehabilitation 
programs. Benzo et al found that pulmonary rehabilitation 
resulted in improvements in energy fatigue scores on the 
SF-36.24 In contrast, a recent randomized controlled trial 
conducted by Theander et al was unable to detect improve-
ments in fatigue levels following pulmonary rehabilitation.15 
Inconsistent measurement of fatigue between studies may 
account for this discrepancy.
Limited research has been conducted to examine various 
factors that influence fatigue as well as some dimensions of 
fatigue in individuals with COPD. Our study examined four 
dimensions of subjective fatigue in a group of individuals 
with COPD and several factors previously identified in the 
literature as influencing fatigue.
Methods
Research design
A descriptive, cross-sectional survey design using previously 
validated measures was used to assess fatigue. The theory 
of unpleasant symptoms was used as the conceptual model 
guiding this study.25 Subjective fatigue, the unpleasant symp-
tom under consideration, was conceptualized to include four 
dimensions: emotional, behavioral, cognitive, and physical. 
These four dimensions were explored in terms of their rela-
tionships to physiologic, psychologic, and situational factors 
which may influence fatigue.
Setting and participants
The setting was an outpatient pulmonary rehabilitation pro-
gram offered at two sites in the city of Saskatoon in the Saska-
toon Health Region. This program is available to patients with 
COPD confirmed by spirometry,1 and who are symptomatic 
regardless of severity of disease.22 Eligibility criteria for the 
study included a physician-confirmed diagnosis of COPD, 
able to read, write, understand, and communicate in English, 
and aged 18 years or older. The program is designed for a 
duration of 12 months; however, participants may continue 
to participate past that time. Participants engage in monitored 
physical activity and receive education on numerous topics. 
All participants completed an eight-week initiation program 
in pulmonary rehabilitation and were currently in the mainte-
nance phase. Ongoing program evaluation reveals clinically 
meaningful and statistically significant improvements in 
exercise limitation (improved walking distance) and qual-
ity of life (reduced St George’s Respiratory Questionnaire 
score) at 3, 6, and 12 months following enrolment (personal 
communication, D Marciniuk, Medical Director, Saskatoon 
Pulmonary Rehabilitation Program).
Recruitment and data collection took place simultane-
ously between October 2008 and December 2008, for a total 
period of two months. Participants who were determined by 
the program coordinator to have met the eligibility criteria 
for the study were approached by the researcher. Forty-two 
of the 45 participants approached agreed to participate, giving International Journal of Chronic Obstructive Pulmonary Disease 2010:5 submit your manuscript | www.dovepress.com
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a participation rate of 93.3%. The researcher met with each 
participant individually and distributed a demographic form, 
as well as several questionnaires which assessed fatigue, 
anxiety, depression, and sleep quality. Participants were 
asked to complete all forms during that meeting. The par-
ticipants were deemed stable by their physician to engage in 
the physical exercise component of the program. Some of the 
participants had completed the 12-month program, and con-
tinued to enroll for maintenance purposes, while others had 
not completed the program. Ethical approval was obtained 
from the University of Saskatchewan Behavioral Research 
Ethics Board, and operational approval was obtained from 
the Saskatoon Health Region. All subjects provided informed 
consent to participate.
Instruments
Fatigue
The MFI-20 was used to measure subjective fatigue.17 The 
MFI-20 is comprised of 20 items divided into five subscales 
which measure the primary dimensions of fatigue, including 
general fatigue, physical fatigue, reduced activity, reduced 
motivation, and mental fatigue. The general and physical 
fatigue subscales measured the physical dimension of fatigue. 
The reduced activity, reduced motivation, and mental fatigue 
subscales measured the behavioral, emotional, and cognitive 
dimensions of fatigue, respectively. The five dimensions of 
fatigue in the instrument were based on how fatigue could be 
expressed, which included a general evaluation about one’s 
functioning, physically feeling tired, cognitive indications, 
being less motivated, and engaging in fewer activities.26 
Each of the five subscales relate to these dimensions and 
contain four items which are rated on a scale from 1 to 5, 
where one indicates “yes, that is true” and five indicates 
“no, that is not true”. A total score is calculated for each 
subscale, where scores range from 4 to 20, and higher scores 
indicating more fatigue. The instrument demonstrates good 
internal consistency with average Cronbach’s alpha scores 
of 0.86.26,27 The MFI has previously been used in studies of 
persons with COPD.28,29
Anxiety and depression
Anxiety and depression were measured using the Hospital 
Anxiety and Depression Scale (HADS).30 The ease, speed, 
patient acceptance, and validated psychometric properties of 
the HADS allow it to be applied to a wide variety of clinical 
populations where significant anxiety and depression may 
coexist with the manifestation of physical illness, including 
COPD.31 This widely used instrument contains 14 items, 
of which seven items measure symptoms of depression 
  occurring in the past week, while the remainder measure 
symptoms of anxiety occurring in the past week. Each item 
is rated on a four-point scale; item scores are summed to 
yield subscores for anxiety and depression. Scores can range 
between 0 and 21. Scores between 8 and 10 on either subscale 
suggest mild anxiety or depression, while scores between 11 
and 14 are considered moderate, and those 15 or above are 
considered severe.
Sleep quality
The Pittsburgh Sleep Quality Index (PSQI) was used to 
measure sleep quality.32 The scale is comprised of 19 items 
divided into seven components: sleep quality, sleep latency, 
sleep duration, habitual sleep efficiency, sleep disturbances, 
use of sleep medications, and daytime dysfunction. Each 
item is rated on a scale from 0 to 3, where zero indicates no 
difficulty and three indicates severe difficulty. A Global Sleep 
Quality Index is calculated with scores ranging between 0 
and 21; scores of 5 or more on the index indicate poor sleep 
quality.32 The PSQI has been found to have high internal 
consistency,32,33 test-retest reliability, concurrent validity, 
and construct validity.32
Dyspnea
The Medical Research Council (MRC) dyspnea scale was 
used to assess dyspnea.34
Activity limitation
The most recent 6-minute walk test (6MWT) available 
in the health record was used as a measure of functional 
activity limitation.35 The 6MWT is performed at the start 
of the program, as well as after three, six, and 12 months of 
participation in the program.
Additional data
Further data gathered from the health record included smok-
ing status, duration of enrolment in pulmonary rehabilitation, 
comorbidities, supplemental oxygen use, respiratory medica-
tions, and the most current oxygen saturation readings from 
pulse oximetry (recorded immediately after walking).
Data analysis
Data were entered into SPSS software (v. 16.0; SPSS Inc., 
Chicago, IL) and recoded as required according to the 
questionnaires’ scoring instructions. Descriptive and Spearman’s 
rho correlational analyses were conducted. Comparisons in pro-
portions between groups were completed using Chi-square or International Journal of Chronic Obstructive Pulmonary Disease 2010:5 submit your manuscript | www.dovepress.com
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Kruskal–Wallis tests of proportion. Statistical significance for 
the bivariate analysis was set at P # 0.05.
Results
Forty-two of the 45 participants enrolled in the study, and 
40% (17) were male, with a mean age of 72.9 years (stan-
dard deviation [SD] ± 6.5, range 56–87). Although recent 
spirometry results from only 14 participants were available 
in the program site health records, they indicate that those 
subjects had a forced expiratory volume in one second/
forced vital capacity (FEV1/FVC) of less than 0.7, and the 
mean FEV1 was 47.8% of the predicted, confirming some 
presence of severe COPD in this limited sample.1 Only 
14 participants had recent spirometry results kept on file at 
their pulmonary rehabilitation facility because the results 
are normally kept at their physicians’ office and are sent to 
the pulmonary rehabilitation facility upon request. Due to 
the limited number of spirometry results available, we did 
not find a correlation between severity of COPD and fatigue. 
Data on the total number of comorbidities were gathered, 
which included any coexisting diseases and excluded the 
diagnosis of COPD. The median number was three, and 
52.4% (22) had three or more comorbidities. More than 
three-quarters of participants (33) were exsmokers, 4.8% 
(2) were nonsmokers, and 16.7% (7) were current smok-
ers. Supplemental oxygen was used by 26.2% (11) of the 
participants. There were a total of 16 participants who 
began pulmonary rehabilitation between 2002 and 2006, 
seven who began in 2007, and 19 who began in 2008. Most 
participants had attended pulmonary rehabilitation for 
just over two years. The average length of attendance was 
25 months (SD ± 26). The MRC dyspnea scores were avail-
able for 30 participants. The scores ranged from Grade 1 
(not troubled with breathlessness except with strenuous 
exercise) to Grade 4 (too breathless to leave the house or 
breathless when dressing or undressing), with 53.3% of 
participants reporting dyspnea at a Grade 3 level. Sample 
characteristics are summarized in Table 1.
Mean scores for MFI subscales ranged from 11.1 (gen-
eral fatigue) to 13.5 (physical fatigue), as seen in Table 2. 
Reliability (Cronbach’s α) scores for the subscales were: 
general fatigue 0.63; physical fatigue 0.69; reduced activity 
0.67; reduced motivation 0.70; and mental fatigue 0.76. No 
associations were detected between fatigue subscale scores 
and gender, age group, sleep quality, 6MWT distance, MRC 
dyspnea grade, use of supplemental oxygen, high or low 
oxygen saturation levels, smoking status, or presence of three 
or more comorbidities.
Almost half (42.9%) of the participants had experienced 
anxiety over the previous week. Scores on the HADS classi-
fied nine (21.4%) participants as experiencing mild anxiety 
during the previous week, eight (19.0%) with moderate anxi-
ety, and one (2.4%) with severe anxiety. Most participants 
(78.6%) had no symptoms of depression, although eight 
(19.0%) had mild symptoms and one (2.4%) experienced 
severe symptoms of depression. The participant who was 
classified as experiencing severe symptoms of anxiety also 
had mild symptoms of depression, while the individual 
classified as having severe symptoms of depression had a 
moderate score on anxiety.
The majority of participants (69.0%) were considered 
to experience poor sleep quality. Eight participants (19.0%) 
rated the quality of their sleep as fairly or very bad. Par-
ticipants’ mean duration of sleep was 6.9 hours per night 
(SD = 1.4), although the mean number of hours spent in 
bed was 8.5 (SD = 1.2). One-third (33.0%) of participants 
reported that they awoke once a week or more because they 
could not breathe comfortably, with an equal proportion 
reporting that they awoke once a week or more because of 
pain. Medications to promote sleep were used by 14 (33.3%) 
participants once a week or more.
Table 3 presents the results of correlational analyses 
between fatigue, anxiety and depression, sleep quality, and 
demographic and clinical variables. Significant positive 
correlations were noted between age and reduced activ-
ity (ρ = 0.43, P , 0.01), and age and reduced motivation 
(ρ = 0.31, P , 0.05). An inverse relationship was found 
between anxiety and reduced motivation (ρ = −0.47, 
P , 0.01).
Discussion
In contrast with the 43%–58% prevalence of fatigue reported 
by others for persons with COPD in general,4,5,21 fatigue was 
experienced by almost all participants in this sample of pul-
monary rehabilitation patients. Physical fatigue and fatigue 
related to reduced activity were the MFI subscales with the 
highest (most negative) scores at 13.5 and 13.0, respectively. 
Our findings are similar to those of Breslin et al,28 who also 
found that physical fatigue (14.5) and reduced activity (14.2) 
were dimensions of the MFI most negatively rated by persons 
with COPD. The mean subscale score for reduced motivation 
(12.8) in our sample was higher (worse) than scores reported 
by Hagelin et al for patients in palliative care (11.1), patients 
receiving radiotherapy (9.9), outpatients (8.3), or hospital 
staff (7.0),27 and by Breslin et al for persons with COPD 
(11.1).28 While neither our study nor that of Breslin et al found International Journal of Chronic Obstructive Pulmonary Disease 2010:5 submit your manuscript | www.dovepress.com
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Table 1 Participants’ demographic characteristics and health status
Characteristics n M SD Frequency Percentage
Age (years) 42 72.9  ±6.5
Sex 42
  Male 17 40.5
  Female 25 59.5
Pulmonary function tests 14
  FEV1 (% predicted) 47.8 ±16.3
  FVC (% predicted) 78.9 ±18.1
  FEV1/FVC 0.68 ±0.13
Smoking status 42
  Exsmokers 33 78.6
  Current smokers 7 16.7
  Nonsmokers 2 4.8
MRC dyspnea scale 30 2.6
Comorbidities 42 2.6 ±1.4
Amount of pulmonary rehabilitation  
received (months)
42 25  ±26
6MWT (meters) 41 356  ±90
Oxygen saturation 42 92.6% ±4.1
Heart rate (beats/min) 42 102  ±14.4
Supplemental oxygen use 42
  Yes 11 26.2
  No 31 73.8
Abbreviations: n, number of participants; M, mean; SD, standard deviation; MRC, Medicial Research Council; FEV1/FVC, forced expiratory volume in one second/forced 
vital capacity; 6MWT, 6-Minute Walk Test.
  associations between the fatigue dimension of reduced moti-
vation and depression,28 this particular dimension of fatigue 
may need additional exploration in persons with COPD.
Anxiety and depression are well recognized to be com-
mon comorbidities in persons with COPD and often occur 
  together.36 Furthermore, anxiety and depression have been 
found to contribute significantly to variance in the functional 
status for people with COPD.37 In our study, symptoms of 
anxiety were reported by almost half of participants, with 
21.4% categorized in the moderate to severe anxiety range by 
the HADS. Similar results were reported by Blinderman et al 
in a population of persons with severe COPD.38 Our sample 
may have had a higher prevalence of anxiety as a result of 
measurement differences and sampling bias due to conve-
nience sampling. There may also be circumstances unique to 
the pulmonary rehabilitation setting that increase the likeli-
hood of anxiety. Other studies have documented prevalence 
rates of anxiety in persons with stable COPD in the 10%–19% 
range,36 and a 32% prevalence of moderate to severe anxiety 
in community-dwelling older adults with COPD.6 The inverse 
relationship between anxiety and the reduced motivation 
dimension of fatigue is quite interesting. We speculate that 
the psychologic energy expended in coping with high levels 
of anxiety may reduce motivation to start activities, although 
this hypothesis requires empiric testing.
Almost one-quarter of participants in this sample reported 
symptoms of depression. Our finding is similar to that of sev-
eral other studies, which found that the prevalence of patients 
with severe COPD who experienced depression was between 
18.8% and 25.0%,39,40 although this rate is lower than the 
56% reported for older adults with COPD by Walke et al.6 
While previous studies have reported associations between 
fatigue, anxiety, and depression, we were not able to detect 
an association. This may be the result of inability of the 
HADS to adequately assess depression in this population.36 
Another reason for the lack of association may be the study 
sample size, which may have had insufficient power to find 
an association.
Poor sleep quality was experienced by the majority of 
participants, although we found no associations between 
the dimensions of fatigue and sleep quality. While fatigue 
was a prominent symptom in our sample, a relatively low 
Table 2 Mean and standard deviation for the MFI-20 subscales
Subscale Mean (SD)
General fatigue 11.1 (2.3)
Physical fatigue 13.5 (2.2)
Reduced activity 13.0 (2.3)
Reduced motivation 12.8 (2.6)
Mental fatigue 11.2 (1.8)
Abbreviations: SD, standard deviation; MFI-20, Multidimensional Fatigue Inventory.International Journal of Chronic Obstructive Pulmonary Disease 2010:5 submit your manuscript | www.dovepress.com
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  proportion (19%) of participants self-rated their sleep as 
fairly or very bad, suggesting that the proposed link between 
fatigue, self-rated sleep quality, and objective sleep quality 
requires further investigation.
There was a significant positive relationship between age 
and reduced activity, as well as age and reduced motivation. 
A possible explanation for this finding is that with the natu-
ral process of aging, participants experienced a decrease in 
physical strength which may have negatively impacted their 
ability to carry out activities of daily living. With a decrease 
in physical strength, participants may feel less motivated to 
engage in activities.
In our study, the dimensions of fatigue were not associ-
ated with any of the clinical variables, including dyspnea. 
This may have resulted from the use of existing health record 
data, which had been collected at varying times over the 
course of the program, and from not having the participants’ 
dyspnea and fatigue measured concurrently. Previous studies 
have noted significant relationships between dyspnea and 
fatigue.4,9,15,41 There have been inconsistent findings on the 
relationship between activity limitation and fatigue.25,26,42,43 
However, we speculate that the various assessment time 
intervals at which the 6MWT was conducted among the 
participants, and the use of the most recent 6MWT distance 
available, may account for the lack of a significant relation-
ship between activity limitation and fatigue.
Our study is one of the few to examine different dimen-
sions of fatigue in persons attending pulmonary rehabilitation. 
The small sample size, convenience sampling, absence of a 
control group, and low reliability coefficients of the MFI are 
limitations to our study. Only individuals with COPD who 
attended pulmonary rehabilitation were included in the study. 
It is possible that the individuals with COPD who attended pul-
monary   rehabilitation were more motivated or experienced less 
anxiety and depression than those individuals with COPD who 
did not attend pulmonary rehabilitation. Selection bias may have 
also affected our findings because individuals for whom fatigue 
was a problem may have been more likely to volunteer for this 
study. However, the high response rate of 95% for those who 
were approached makes this unlikely. Due to the high variability 
in the amount of pulmonary rehabilitation the participants had 
received, it is possible that the participants enrolled in the pro-
gram for a longer period of time had experienced less fatigue. 
There were also limited data available for dyspnea scores and 
pulmonary function tests. It would have been beneficial to 
conduct repeat clinical assessments (pulmonary function tests, 
oxygen saturation, respiratory rate, MRC scores, and 6MWT) 
on the same day as questionnaire completion to ensure currency. 
Longitudinal assessments of fatigue would be useful outcome 
data for the program. In addition, qualitative data relating to 
the participants’ perceptions of fatigue, its impact on their 
daily functioning, and their attributions of the causes of fatigue 
would be helpful in providing a more in-depth portrait of this 
phenomenon. The reliability coefficients for general fatigue, 
physical fatigue, and reduced activity subscales of the MFI 
were less than 0.7 in this sample. The MFI has not been used 
extensively in the population with COPD, and further testing 
of the instrument is warranted.
Conclusion
Fatigue was experienced by almost all participants of a 
pulmonary rehabilitation program in our study, particularly 
in terms of physical fatigue and reduced motivation. Scores 
on the reduced motivation subscale of the MFI for our par-
ticipants exceeded those previously reported for both COPD 
and cancer patients, and warrant additional exploration in 
Table 3 Correlations between fatigue dimensions and demographic, clinical, Pittsburgh Sleep Quality Index, and HADS scores
General fatigue Physical fatigue Reduced activity Reduced motivation Mental fatigue
Age -0.01 0.11 0.43* 0.37* -0.09
MRC score -0.11 -0.33 0.12 -0.09 -0.04
6MWT -0.17 -0.11 -0.25 -0.07 0.11
Heart rate 0.02 -0.21 -0.08 0.09 -0.04
Oxygen saturation -0.10 0.24 -0.11 -0.02 0.05
Comorbidities 0.20 0.17 0.16 0.12 0.05
Amount of pulmonary  
rehabilitation received
-0.02 0.06 0.08 0.22 -0.03
PSQI (sleep quality) 0.04 -0.19 -0.07 -0.05 0.16
HADS (anxiety) 0.23 -0.23 -0.28 -0.47** -0.22
HADS (depression) 0.00 -0.22 -0.29 -0.20 -0.30
Notes: *Correlation is significant at the 0.05 level (two-tailed); **Correlation is significant at the 0.01 level (two-tailed).
Abbreviations: HADS, Hospital Anxiety and Depression Scale; 6MWT, 6-Minute Walk Test; MRC, Medical Research Council; PSQI, Pittsburgh Sleep Quality Index.International Journal of Chronic Obstructive Pulmonary Disease 2010:5 submit your manuscript | www.dovepress.com
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the   pulmonary rehabilitation population. Similarly, our 
finding that rates of anxiety among pulmonary rehabilita-
tion participants appear higher than those reported for the 
overall COPD population suggests that additional focus 
may need to be placed on anxiety management strategies 
within such programs. The incorporation of baseline and 
ongoing assessments of fatigue in the care of participants of 
pulmonary rehabilitation programs may provide important 
data regarding the efficacy of symptom control and rehabili-
tation strategies.
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